REZOLUTE, INC. Liabilities, Noncurrent
REZOLUTE, INC. (RZLT) had Liabilities, Noncurrent of $2.12 million as of 2019-06-30, per its 10-K filed 2019-09-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2019-09-10
- 2019-06-30: Liabilities, Noncurrent $2.12M.
- 2018-09-30: Liabilities, Noncurrent $173.27K.
- 2018-06-30: Liabilities, Noncurrent $215.62K.
- 2018-03-31: Liabilities, Noncurrent $237.40K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2019-06-30 | $2.12M 10-K · filed 2019-09-10 |
| 2018-09-30 | $173.27K 10-Q · filed 2018-12-14 |
| 2018-06-30 | $215.62K 10-Q · filed 2018-12-14 |
| 2018-03-31 | $237.40K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $268.73K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $299.18K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $329.62K 10-K · filed 2018-10-15 |
| 2017-03-31 | $314.65K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $335.59K 10-Q · filed 2017-02-02 |
| 2016-09-30 | $367.81K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $400.04K 10-K · filed 2017-09-22 |
| 2016-03-31 | $431.34K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $460.79K 10-Q · filed 2016-02-16 |
| 2015-09-30 | $453.59K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $503.62K 10-K · filed 2016-09-28 |
| 2015-03-31 | $553.45K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $534.72K 10-Q · filed 2015-02-17 |
| 2014-09-30 | $354.76K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $33.88K 10-K · filed 2015-09-28 |
| 2013-06-30 | $0.00 10-K · filed 2014-09-30 |
| 2012-06-30 | $0.00 10-K · filed 2013-09-11 |
| 2011-12-31 | $54.96K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |